Correction: Posttreatment pulse rate reduction and not baseline pulse rate as an indicator of blood pressure response to nebivolol: a subanalysis from the real-world BENEFIT-KOREA study.

IF 2.6 Q2 PERIPHERAL VASCULAR DISEASE

Clinical Hypertension Pub Date : 2025-07-01 eCollection Date: 2025-01-01 DOI:10.5646/ch.2025.31.e24

Jinho Shin, Dong Hoon Cha, Woo-Hyung Bae, In Hyun Jung, Seung-Pyo Hong, Sang-Hyun Kim, Jun-Young Do, Won Min Hwang, Young Youp Koh, Giuseppe Mancia, Athanasios J Manolis, MinYoung Lee

引用次数: 0

Abstract

[This corrects the article e8 in vol. 31, PMID: 40083595.].

查看原文本刊更多论文

更正：治疗后脉搏率降低，而不是基线脉搏率作为奈比洛尔血压反应的指标：来自现实世界BENEFIT-KOREA研究的一项亚分析。

[这是对第31卷第8篇文章的更正，PMID: 40083595]。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Hypertension PERIPHERAL VASCULAR DISEASE-

CiteScore

5.40

自引率

4.80%

发文量

审稿时长

6 weeks